These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 7819052)

  • 21. Expression of c-erbB-2 oncoprotein in transitional cell bladder cancer.
    Lipponen P
    Eur J Cancer; 1993; 29A(5):749-53. PubMed ID: 8097100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HER-2--a possible target for therapy of metastatic urinary bladder carcinoma.
    Wester K; Sjöström A; de la Torre M; Carlsson J; Malmström PU
    Acta Oncol; 2002; 41(3):282-8. PubMed ID: 12195748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical analysis of nm23 protein in transitional cell carcinoma of the bladder.
    Shiina H; Igawa M; Urakami S; Shirakawa H; Ishibe T
    Br J Urol; 1995 Dec; 76(6):708-13. PubMed ID: 8535713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients.
    Li CC; Chang TH; Wu WJ; Ke HL; Huang SP; Tsai PC; Chang SJ; Shen JT; Chou YH; Huang CH
    Eur Urol; 2008 Nov; 54(5):1127-34. PubMed ID: 18243511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. c-jun oncogene expression in transitional cell carcinoma of the urinary bladder.
    Tiniakos DG; Mellon K; Anderson JJ; Robinson MC; Neal DE; Horne CH
    Br J Urol; 1994 Dec; 74(6):757-61. PubMed ID: 7827848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of epidermal growth factor receptor in urinary bladder cancer metastases.
    Bue P; Wester K; Sjöström A; Holmberg A; Nilsson S; Carlsson J; Westlin JE; Busch C; Malmström PU
    Int J Cancer; 1998 Apr; 76(2):189-93. PubMed ID: 9537579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secondary bladder cancer after upper tract urothelial carcinoma in the US population.
    Kates M; Badalato GM; Gupta M; McKiernan JM
    BJU Int; 2012 Nov; 110(9):1325-9. PubMed ID: 22564365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Primary upper urinary tract tumors and subsequent location in the bladder].
    Azémar MD; Audouin M; Revaux A; Misraï V; Comperat E; Bitker MO; Chartier-Kastler E; Richard F; Cussenot O; Rouprêt M
    Prog Urol; 2009 Oct; 19(9):583-8. PubMed ID: 19800544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Transitional cell carcinoma of the upper urinary tract following total cystectomy for bladder cancer].
    Hayashi Y; Tawada T; Ando Y
    Hinyokika Kiyo; 1992 Sep; 38(9):1015-8; discussion 1018-9. PubMed ID: 1414752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reappraisal of the biological role of epidermal growth factor receptor in transitional cell carcinoma.
    Chow NH; Tzai TS; Lin SN; Chan SH; Tang MJ
    Eur Urol; 1993; 24(1):140-3. PubMed ID: 8365434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
    Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
    BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tract.
    Krabbe LM; Bagrodia A; Haddad AQ; Kapur P; Khalil D; Hynan LS; Wood CG; Karam JA; Weizer AZ; Raman JD; Remzi M; Rioux-Leclercq N; Haitel A; Roscigno M; Bolenz C; Bensalah K; Sagalowsky AI; Shariat SF; Lotan Y; Margulis V
    J Urol; 2015 May; 193(5):1486-93. PubMed ID: 25451830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of HER2 protein overexpression in non-muscle-invasive bladder cancer with emphasis on tumour grade and recurrence].
    Janane A; Hajji F; Ismail TO; Elondo JC; Ghadouane M; Ameur A; Abbar M; Bouzidi A
    Actas Urol Esp; 2011 Apr; 35(4):189-94. PubMed ID: 21419519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase III, Double-Blind, Randomized Trial That Compared Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 1/2-Positive Metastatic Bladder Cancer.
    Powles T; Huddart RA; Elliott T; Sarker SJ; Ackerman C; Jones R; Hussain S; Crabb S; Jagdev S; Chester J; Hilman S; Beresford M; Macdonald G; Santhanam S; Frew JA; Stockdale A; Hughes S; Berney D; Chowdhury S
    J Clin Oncol; 2017 Jan; 35(1):48-55. PubMed ID: 28034079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of human E-cadherin (ECD) correlated with invasiveness of transitional cell cancer in the renal pelvis, ureter and urinary bladder.
    Wakatsuki S; Watanabe R; Saito K; Saito T; Katagiri A; Sato S; Tomita Y
    Cancer Lett; 1996 May; 103(1):11-7. PubMed ID: 8616803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. c-erbB-2 (HER-2/neu) oncopeptide immunoreactivity in localized, high-grade transitional cell carcinoma of the bladder.
    Swanson PE; Frierson HF; Wick MR
    Mod Pathol; 1992 Sep; 5(5):531-6. PubMed ID: 1364264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary pH Levels are Strongly Associated with Bladder Recurrence After Nephroureterectomy in Upper Tract Urothelial Carcinoma Patients with a Smoking History.
    Ide H; Kikuchi E; Hagiwara M; Hayakawa N; Hongo H; Miyajima A; Oya M
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):1029-1038. PubMed ID: 27613550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract.
    Matsui Y; Utsunomiya N; Ichioka K; Ueda N; Yoshimura K; Terai A; Arai Y
    Urology; 2005 Feb; 65(2):279-83. PubMed ID: 15708038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical Analysis of HER2, EGFR, and Nectin-4 Expression in Upper Urinary Tract Urothelial Carcinoma.
    Hashimoto M; Fujita K; Tomiyama E; Fujimoto S; Adomi S; Banno E; Minami T; Takao T; Nozawa M; Fushimi H; Yoshimura K; Nonomura N; Uemura H
    Anticancer Res; 2023 Jan; 43(1):167-174. PubMed ID: 36585180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upper tract transitional cell carcinoma following cystectomy for bladder cancer.
    Huguet-Pérez J; Palou J; Millán-Rodríguez F; Salvador-Bayarri J; Villavicencio-Mavrich H; Vicente-Rodríguez J
    Eur Urol; 2001 Sep; 40(3):318-23. PubMed ID: 11684849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.